How long should a patient follow up with a provider if she has no menstrual bleeding after a Depo‑Provera (medroxyprogesterone acetate) injection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Amenorrhea After Depo-Provera Does Not Require Routine Follow-Up

Amenorrhea (absence of menstrual bleeding) after Depo-Provera injection is an expected and normal side effect that does not require any specific follow-up timeline or medical treatment. 1

Understanding Amenorrhea with Depo-Provera

Amenorrhea is extremely common with DMPA use and increases with duration:

  • 55% of women have no menstrual bleeding after 1 year of use
  • 68% have amenorrhea after 2 years of use 2

This is not harmful and requires only reassurance 1. The guidelines are explicit: "Amenorrhea does not require any medical treatment. Provide reassurance." 1

When to Follow Up

Only Two Scenarios Warrant Provider Contact:

  1. If the bleeding pattern changes abruptly from regular bleeding to sudden amenorrhea - consider ruling out pregnancy if clinically indicated 1

  2. If the patient finds amenorrhea unacceptable and wants to discuss alternative contraceptive methods 1

Routine Pregnancy Testing Timeline:

If there is uncertainty about whether the patient might be pregnant when starting DMPA, follow up with a pregnancy test in 2-4 weeks 1. However, if the patient has been receiving regular injections every 13 weeks and has no other concerning symptoms, pregnancy is unlikely even with amenorrhea 3.

Key Clinical Pitfalls to Avoid

Do not treat amenorrhea as a problem requiring investigation. The most common error is over-medicalizing this expected side effect, which can undermine patient confidence in the method.

Pre-injection counseling is critical: Patients should be informed before their first injection that amenorrhea is common, expected, and not harmful 1. Studies show that women counseled about expected bleeding changes before starting DMPA are more likely to continue the method 2.

When Amenorrhea Becomes Concerning

The only time amenorrhea requires evaluation is when:

  • The patient's regular bleeding pattern abruptly changes to amenorrhea (suggesting possible pregnancy)
  • The patient has missed their scheduled 13-week injection by more than 2 weeks (15+ weeks from last injection) and has been sexually active 1
  • The patient has other symptoms suggesting pregnancy or pathology

Bottom line: No menses after Depo-Provera is the expected outcome for most long-term users. No specific follow-up timeline is needed unless the patient has concerns, wants to switch methods, or there is clinical suspicion of pregnancy.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.